Mark Westerman founded Intrinsic LifeSciences (ILS) in 2006 along with Drs. Tomas Ganz and Elizabeta Nemeth, and served as President & CEO until his passing.
Dr. Westerman and his corporate and academic colleagues discovered and characterized bass hepcidin soon after its discovery in humans by Tomas Ganz (UCLA, David Geffen School of Medicine). He was instrumental in development of a novel serum hepcidin ELISA and was awarded two patents related to the company’s products.
Mark Westerman’s Selected Publications:
For the full list of publications, click here http://www.ncbi.nlm.nih.gov/pubmed?term=hepcidin%20OR%20la%20jolla%20OR%20college%20station%20AND%20westerman%20m